Abstract LB-142: Marked efficacy of difluoromethylornithine plus sulindac in reducing recurrent colorectal adenomas in patients with prior adenomas: Results of a randomized, placebo-controlled, double-blind Phase III trial.
Year: 2008
Type: conference-abstract
Source: Cancer Research
Institutions: UC Irvine Chao Family Comprehensive Cancer Center, University of Arizona, University of California, Irvine, Kaiser Permanente, Kaiser Permanente Sacramento Medical Center, United States Department of Veterans Affairs, Loma Linda University, Denver VA Medical Center, University of Colorado Anschutz, University of Colorado Denver, University of Michigan
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2944307022